Business · 03/08/2010Updated: 10/17/2026 · 1 min read
FDA Hosts Public Workshop on Clinical Trials of Aerosolized Antimicrobials for Cystic Fibrosis Treatment
Summary
The FDA is hosting a public workshop to gather input from healthcare providers, patients, and industry on the design of clinical trials for aerosolized antimicrobials to treat cystic fibrosis, a chronic bacterial infection in the lungs that improves respiratory symptoms in patients.
Original source language: Federal Register — Health and Human ServicesOpen original release →